Kereena Chukka et al. 2021. Study on CD44 as a Cancer Stem Cell Marker for Head and Neck Squamous Cell Carcinoma. Highlights on Medicine and Medical Science Vol. 12. (Jul. 2021), 118–123. DOI:https://doi.org/10.9734/bpi/hmms/v12/10882D.